Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Hetzer Medical Indonesia Tbk. (MEDS) Price & Performance

UBC Medical Indonesia Tbk.Trade
Hetzer Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Hetzer Medical Indonesia Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Hetzer Medical Indonesia Tbk. trades at Rp86 (market cap 139.06B, 51.66M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 5× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (51.66M versus 635.5K). Which is the better fit depends on your goals.

LABSMEDS
Market Cap
691.25B139.06B
Volume
635.5K51.66M
Lot
6.36K516.62K
Turnover
110.15M4.44B
Average Price
173.3385.97
Value
110.15M4.44B
Indicative Equilibrium Price
17486
Indicative Equilibrium Volume
509.62K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MEDS
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Hetzer Medical Indonesia Tbk.

PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.

Read more on MEDS